Chemical Structure : Leriglitazone
货号: PC-49255Not For Human Use, Lab Use Only.
MIN-102 (Leriglitazone) is a novel brain penetrant, selective and orally bioavailable PPARγ agonist with a potential best-in-class profile indicated for CNS diseases.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MIN-102 (Leriglitazone) is a novel brain penetrant, selective and orally bioavailable PPARγ agonist with a potential best-in-class profile indicated for CNS diseases.
MIN-102 (Leriglitazone) increases frataxin levels and mitochondrial markers in FRDA models.
MIN-102 (Leriglitazone) protects from neurodegeneration by improving mitochondrial function.
MIN-102 (Leriglitazone) prevents lipid droplets formation in frataxin-deficient cardiomyocytes.
MIN-102 (Leriglitazone) rescues the motor function deficit of the YG8sR mice.
MIN-102 (Leriglitazone) emerges as a potential therapeutic agent for Friedreich Ataxia.
分子量 | 372.439 | |
分子式 | C19H20N2O4S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Laura Rodríguez-Pascau, et al. Neurobiol Dis. 2021 Jan;148:105162.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright